Compulsory licensing remains one of the most closely watched and debated areas of intellectual property law. While used infrequently in many jurisdictions, compulsory licences continue to play an important role in discussions surrounding access to technology, public policy, competition, public health, and the balance between exclusive rights and broader societal interests.
This category covers legal and policy developments relating to compulsory licences and other forms of non-voluntary licensing across patents, copyright, and related rights. Our contributors analyse legislative initiatives, court decisions, administrative actions, and international developments that influence how compulsory licensing frameworks are interpreted and applied in practice.
Topics covered include pharmaceutical and healthcare innovation, standard-essential patents (SEPs), competition law considerations, government use provisions, technology transfer, and emerging debates arising from the digital and green transitions. We also examine developments at the national, regional, and international level, including initiatives discussed within the World Trade Organization (WTO), World Intellectual Property Organization (WIPO), and other policymaking forums.
For IP professionals, policymakers, in-house counsel, and private practitioners, this section provides timely analysis of compulsory licensing developments and their implications for intellectual property strategy, innovation, and market access.
In my last post I deciphered several fake news, which spoil the public debate about compulsory licensing, I then mentioned a French bill proposal, introduced by Mr. Ronan Le Gleut in the Senate on…
At a time when a bill aiming at granting a compulsory license in the interest of public health in case of extreme sanitary emergency has just been filed in the French Senate on April 8, 2021[1], the…
Regular readers of the Blog may be aware of my particular interest in pharma patents and, more especially since the Covid-19 pandemic, for compulsory licensing (see for instance here). I was…
At the beginning of the year, the Russian Government granted the first compulsory license on a series of Big Pharma's patents.
For the first time ever, "public security” clause has been evoked…
The Odyssey, which became synonymous for an eventful journey, originally refers to the perilous return of Odysseus to his homeland of Ithaca after the Trojan War. After the year 2020, marked by the…
In his 1913 essay Totem und Taboo, Freud defined taboo as a prohibition related to what is considered sacred or impure. The famous psychoanalyst insists on the irrationality of the phenomenon. Thus,…
As many laboratories around the world are making every effort to find a treatment for Covid-19 and more clinical trials are conducted[1], it is worth considering the legal mechanisms that could…
As many laboratories around the world are making every effort to find a treatment for Covid-19 and more clinical trials are conducted[1], it is worth considering the legal mechanisms that could…
Discussions are under way at the World Intellectual Property Organization (WIPO) and the World Health Organization (WHO) on enabling wider access to some patented drugs and medical supplies during…